Gastroenterol Res Pract. 2018 Aug 12;2018:6417526. doi: 10.1155/2018/6417526. eCollection 2018.
On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis.
Gastroenterology research and practice
Zubair Khan, Yaseen Alastal, Muhammad Ali Khan, Mohammad Saud Khan, Basmah Khalil, Shreesh Shrestha, Faisal Kamal, Ali Nawras, Colin W Howden
Affiliations
Affiliations
- Division of Gastroenterology and Hepatology, University of Toledo Medical Center, Toledo, OH, USA.
- Division of Gastroenterology and Hepatology, The University of Tennessee Health Science Center, Memphis, TN, USA.
PMID: 30158966
PMCID: PMC6109549 DOI: 10.1155/2018/6417526
Abstract
BACKGROUND: Proton pump inhibitors (PPIs) are widely used for the long-term management of gastroesophageal reflux disease (GERD). However, concerns about the cost and/or inconvenience of continuous maintenance PPI treatment have led to the evaluation of various alternative approaches.
AIM: To assess the effectiveness of on-demand PPI therapy in the maintenance treatment of nonerosive reflux disease (NERD) or mild erosive esophagitis (EE).
METHODS: We searched MEDLINE, EMBASE, Web of Science, and Cochrane Library from inception until October 2, 2017, for randomized controlled trials (RCTs) comparing on-demand PPI versus placebo or daily PPI in the management of NERD or mild EE (Savary-Miller grade 1). Discontinuation of therapy during the trial was used as a surrogate for patient dissatisfaction and failure of symptomatic control. We calculated pooled odds ratios (OR) to evaluate the efficacy of on-demand PPI treatment. Separate analyses were conducted for studies comparing on-demand PPI with daily PPI and with placebo. Subgroup analysis was done based on NERD studies alone and on studies of both NERD and mild EE. These were analyzed using a random effects model.
RESULTS: We included 10 RCTs with 4574 patients. On-demand PPI was superior to daily PPI (pooled OR = 0.50; 95% confidence interval (CI) = 0.35, 0.72). On subgroup analysis in NERD patients only, pooled OR was 0.44 (0.29, 0.66). In studies including patients with NERD and mild EE, pooled OR was 0.76 (0.36, 1.60). For studies comparing on-demand PPI with placebo, pooled OR was 0.21 (0.15, 0.29); subgroup analyses of studies evaluating NERD only and studies conducted in NERD and mild EE showed similar results (pooled OR was 0.22 (0.13, 0.36) and 0.18 (0.11, 0.31), resp.).
CONCLUSIONS: On-demand PPI treatment is effective for many patients with NERD or mild EE. Although not FDA-approved, it may be adequate for those patients whose symptoms are controlled to their satisfaction.
References
- Aliment Pharmacol Ther. 1999 Jul;13(7):907-14 - PubMed
- Aliment Pharmacol Ther. 2004 Jul 15;20(2):181-8 - PubMed
- Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002095 - PubMed
- Digestion. 2008;78 Suppl 1:6-10 - PubMed
- Aliment Pharmacol Ther. 2004 Sep 15;20(6):657-65 - PubMed
- BMC Gastroenterol. 2016 Apr 14;16:48 - PubMed
- Cochrane Database Syst Rev. 2017 Mar 16;3:CD011969 - PubMed
- Therap Adv Gastroenterol. 2012 Jul;5(4):219-32 - PubMed
- Clin Gastroenterol Hepatol. 2007 Jan;5(1):17-26 - PubMed
- Lancet. 2006 Jun 24;367(9528):2086-100 - PubMed
- Am J Gastroenterol. 2007 Mar;102(3):642-53 - PubMed
- Dig Dis Sci. 2000 Apr;45(4):809-18 - PubMed
- BMJ. 2009 Jul 21;339:b2700 - PubMed
- Curr Ther Res Clin Exp. 2005 Jul;66(4):345-63 - PubMed
- BMJ. 2004 Jun 19;328(7454):1490 - PubMed
- Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003245 - PubMed
- J Gastroenterol Hepatol. 2002 Sep;17(9):949-54 - PubMed
- Am J Gastroenterol. 2006 Nov;101(11):2457-62 - PubMed
- Br J Gen Pract. 1999 Jun;49(443):451-3 - PubMed
- Eur J Gastroenterol Hepatol. 2002 Aug;14(8):857-63 - PubMed
- Aliment Pharmacol Ther. 2001 Mar;15(3):347-54 - PubMed
- Scand J Gastroenterol. 2002 Jun;37(6):642-7 - PubMed
- Clin Gastroenterol Hepatol. 2004 Aug;2(8):656-64 - PubMed
- Clin Gastroenterol Hepatol. 2007 Jun;5(6):690-5 - PubMed
- Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943 - PubMed
- Aliment Pharmacol Ther. 2006 Jul 1;24(1):33-45 - PubMed
- Scand J Gastroenterol. 2014 Apr;49(4):409-17 - PubMed
- Hepatogastroenterology. 2013 Jul-Aug;60(125):1077-82 - PubMed
- Am J Gastroenterol. 2006 Sep;101(9):2128-38 - PubMed
- Aliment Pharmacol Ther. 2003 Oct 15;18(8):767-76 - PubMed
- Aliment Pharmacol Ther. 2007 Jul 15;26(2):195-204 - PubMed
- Aliment Pharmacol Ther. 2005 Aug 1;22(3):183-91 - PubMed
- Eur J Gastroenterol Hepatol. 2005 Sep;17(9):935-41 - PubMed
- Gastroenterology. 2001 Nov;121(5):1095-100 - PubMed
- Digestion. 2005;72(2-3):76-85 - PubMed
- Am J Gastroenterol. 2004 May;99(5):946-9 - PubMed
- Aliment Pharmacol Ther. 2011 Jan;33(2):213-24 - PubMed
- Br J Gen Pract. 1999 Jun;49(443):463-4 - PubMed
Publication Types